EASL 2026: Hepatitis C Testing Barriers Delay Early Treatment
Diagnostic Bottlenecks in Global Viral Hepatitis Elimination At the 2026 European Association for the Study of the Liver (EASL) Congress, international health experts identified critical structural and systemic barriers in hepatitis C virus (HCV) testing that continue to obstruct progress toward World Health Organization (WHO) elimination goals. Despite the availability of highly effective direct-acting antivirals,…
